Medexus Pharmaceuticals Inc. Total Liabilities for the year ending March 31, 2025: USD 119.69 M

Medexus Pharmaceuticals Inc. Total Liabilities is USD 119.69 M for the year ending March 31, 2025, a -4.56% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
  • Medexus Pharmaceuticals Inc. Total Liabilities for the year ending March 31, 2024 was USD 125.41 M, a -9.70% change year over year.
  • Medexus Pharmaceuticals Inc. Total Liabilities for the year ending March 31, 2023 was USD 138.88 M, a 14.37% change year over year.
  • Medexus Pharmaceuticals Inc. Total Liabilities for the year ending March 31, 2022 was USD 121.43 M, a -6.94% change year over year.
  • Medexus Pharmaceuticals Inc. Total Liabilities for the year ending March 31, 2021 was USD 130.50 M, a 86.39% change year over year.
Key Data
Date Total Liabilities Shareholders' Equity Cash and Short-Term Investments Receivables